Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone in CIS and Early RRMS (OCTIMS)
NCT00910598Phase 4Unknown
- Sponsor
- Amphia Ziekenhuis
- Start
- Sep 2009
- Primary completion
- Jun 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of glatiramer acetate in multiple sclerosis (MS), sponsored by Amphia Ziekenhuis. Status: unknown.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00910598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910598.